Neorof 1% Infusion

Neorof 1% Infusion is a non-barbiturate hypnotic agent that provides rapid loss of consciousness, typically within one arm-to-brain circulation time (approximately 40 seconds). Its pharmacokinetic profile is defined by a rapid distribution from the blood to the brain and other highly perfused tissues, followed by extensive metabolic clearance. This results in a "clear" recovery with a low incidence of post-operative nausea and vomiting compared to many other anesthetic agents.

The medicine is formulated as an oil-in-water emulsion because the active pharmaceutical ingredient is poorly soluble in water. It does not possess analgesic (pain-relieving) properties, so it is frequently administered alongside opioids or local anesthetics to ensure patient comfort during painful procedures.

Beyond surgical induction, Neorof 1% Infusion is utilized for "monitored anesthesia care" during diagnostic procedures and for providing continuous sedation in critically ill patients. Strict aseptic techniques are mandatory during handling because the emulsion can support the rapid growth of microorganisms.

Neorof 1% Infusion may be indicated by your doctor for:

Induction of General Anesthesia

To rapidly initiate unconsciousness in adults and children before surgery.

Maintenance of General Anesthesia

To keep a patient unconscious throughout the duration of a surgical procedure.

Intensive Care Sedation

Providing sedation for intubated, mechanically ventilated adult patients in an ICU setting.

Monitored Anesthesia Care (MAC)

Providing conscious sedation for diagnostic and therapeutic procedures (e.g., colonoscopy or endoscopy).

Procedural Sedation

Short-term sedation for minor medical interventions or imaging.

Neorof 1% Infusion may provide benefits such as:

• Rapid Onset: Produces a swift transition to anesthesia, reducing the time required for surgical preparation.

• Predictable Recovery: Patients typically wake up quickly and with a "clear head," facilitating faster discharge from recovery rooms.

• Anti-emetic Properties: Has a natural tendency to reduce the risk of nausea and vomiting following anesthesia.

• Ease of Titration: The depth of sedation can be precisely controlled by adjusting the infusion rate.

• Reduced Airway Irritability: Less likely to cause coughing or spasms of the airway during insertion of breathing tubes compared to some inhaled gases.

Common side effects of Neorof 1% Infusion may include

• Pain, burning, or stinging at the injection site

• Nausea or vomiting

• Headache

• Drowsiness or dizziness

Uncommon side effects of Neorof 1% Infusion may include

• Muscle twitching or involuntary movements

• Changes in blood pressure or heart rate

• Confusion or agitation during recovery

• Rash or itching

Serious side effects that require immediate medical attention

• Severe allergic reaction (rash, hives, swelling of face/lips/tongue, difficulty breathing)

• Irregular heartbeat or chest pain

• Severe drop in blood pressure

• Trouble breathing or slowed breathing

• Seizures

• Signs of infection at the injection site (redness, swelling, pain)

• Important note: Propofol is usually given by trained healthcare professionals in hospitals or surgical centers. Because it can affect breathing, heart rate, and blood pressure, close monitoring is required during and after administration.

• Neorof 1% Infusion must only be administered by a qualified clinician trained in anesthesia or emergency airway management.

• It is delivered intravenously, either as a single slow injection (bolus) or a continuous infusion using a specialized pump.

• Continuous monitoring of heart rate, blood pressure, and oxygen saturation is mandatory during administration.

• Oxygen and resuscitation equipment must be immediately available whenever the medicine is used.

• The dosage is strictly individualized based on the patient's weight, age, and medical condition.

Neorof 1% Infusion works by modulating the activity of the primary inhibitory neurotransmitter in the central nervous system, known as gamma-aminobutyric acid (GABA). It binds to GABA-A receptors, enhancing the effects of the neurotransmitter. This action slows down brain activity and inhibits the transmission of nerve impulses, leading to sedation and, at higher doses, a complete loss of consciousness. Because it works so quickly and is rapidly redistributed and metabolized, the depth of anesthesia can be altered almost minute-by-minute by the attending clinician.

• Inform your anesthesiologist about any history of egg or soy allergies before the procedure.

• Arrange for a responsible adult to drive you home and stay with you for 24 hours after receiving this medicine.

• Expect to feel a brief "sting" or "burn" in the vein when the injection starts; this is normal and temporary.

• Avoid making any major legal or financial decisions for 24 hours post-anesthesia, as your judgment may be subtly impaired.

• Tell your doctor if you have high cholesterol or pancreatitis, as Neorof 1% Infusion contains lipids (fats).

• Neorof 1% Infusion is stored by the hospital pharmacy, typically at room temperature (between 15°C to 22°C).

• Do not freeze the emulsion.

• Once a vial is opened, it must be used or discarded within a few hours (typically 6 to 12 hours, depending on the setting) to prevent bacterial growth.

• The medicine should not be used if the emulsion shows signs of separation (oil droplets visible).

• Fasting (Mandatory): Patients must follow "nothing by mouth" (NPO) guidelines provided by their doctor before receiving Neorof 1% Infusion to prevent aspiration.

• Egg/Soy (Unsafe): Because the medicine is formulated in an emulsion of egg lecithin and soybean oil, individuals with severe allergies to these foods are at high risk.

• General Diet (Safe): Once fully awake and cleared by medical staff, most patients can return to a normal diet.

• Opioids (Caution): When used with pain medicines like fentanyl, the risk of breathing problems and low blood pressure increases.

• Benzodiazepines (Caution): Combining with medicines like midazolam causes deeper sedation and slower recovery.

• Inhaled Anesthetics (Caution): Use with gases like sevoflurane requires dose reduction of both agents to prevent excessive anesthesia.

• Valproate (Caution): May increase the blood levels of Neorof 1% Infusion, requiring a lower dose.

• Hyperlipidemia (Caution): Because the drug is carried in a fat emulsion, prolonged use can increase blood triglyceride levels.

• Pancreatitis (Caution): Use with care in patients with a history of pancreatitis, as the lipid load may trigger a flare-up.

• Hypovolemia (Unsafe): Patients with low blood volume or dehydration are at high risk for severe drops in blood pressure.

• Cardiac Disease (Caution): Requires careful monitoring as it can reduce heart output and blood pressure significantly.

Because Neorof 1% Infusion is administered solely by healthcare professionals in a controlled clinical environment, it is not possible for a patient to miss a dose in the traditional sense. The timing and administration are managed entirely by the medical team.